TP53 and colorectal cancer: As regards CD-SBC and CrD-SBC, overexpression of the TP53 gene product has been found in about half of cases in both groups, thus confirming the key role of TP53 alterations in small bowel carcinogenesis [2,8,10], as well as in inflammatory bowel disease-associated colorectal cancers [52].